Black Rock Inc. Inotiv, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Inotiv, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 212,786 shares of NOTV stock, worth $570,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares

212,786

Previous 212,786 -0.0%

Holding current value

$570,266

Previous $2.33 Million 84.83%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$3.27 - $11.04 $10,957 - $36,995	-3,351 Reduced 1.55%	212,786 $2.33 Million
Q3 2023 Nov 13, 2023	SELL	$3.01 - $7.32 $43,970 - $106,930	-14,608 Reduced 6.33%	216,137 $665,000
Q2 2023 Aug 11, 2023	SELL	$4.08 - $7.22 $4.04 Million - $7.16 Million	-991,257 Reduced 81.12%	230,745 $1.1 Million
Q1 2023 May 12, 2023	BUY	$4.18 - $8.64 $539,571 - $1.12 Million	129,084 Added 11.81%	1,222,002 $5.29 Million
Q4 2022 Feb 13, 2023	BUY	$3.77 - $22.1 $223,380 - $1.31 Million	59,252 Added 5.73%	1,092,918 $5.4 Million
Q3 2022 Nov 14, 2022	SELL	$9.81 - $26.17 $228,828 - $610,441	-23,326 Reduced 2.21%	1,033,666 $17.4 Million
Q2 2022 Aug 12, 2022	BUY	$9.56 - $25.91 $699,705 - $1.9 Million	73,191 Added 7.44%	1,056,992 $10.1 Million
Q1 2022 May 12, 2022	BUY	$18.52 - $40.41 $1.06 Million - $2.32 Million	57,382 Added 6.19%	983,801 $25.8 Million
Q4 2021 Feb 10, 2022	BUY	$30.55 - $57.88 $8.03 Million - $15.2 Million	262,728 Added 39.59%	926,419 $39 Million
Q3 2021 Nov 09, 2021	BUY	$23.69 - $49.93 $661,993 - $1.4 Million	27,944 Added 4.4%	663,691 $19.4 Million
Q2 2021 Aug 11, 2021	BUY	$18.9 - $31.42 $12 Million - $20 Million	635,747 New	635,747 $17 Million

Others Institutions Holding NOTV

# of Institutions

Shares Held

3.67M

Call Options Held

1.1K

Put Options Held

21.3K

View Full List

About Inotiv, Inc.

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $68.6M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

More about NOTV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account